← Back to opportunities

Immunoglobulins (2025)

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Buyer Contact Info

Buyer Name: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Buyer Address: 10 South Colonnade, London, UKI42, E14 4PU, United Kingdom

Contact Name: Chantal Jockel

Contact Email: vmc.vaccines@ukhsa.gov.uk

Status
complete
Procedure
open
Value
1.0 GBP
Published
18 Mar 2025, 16:10
Deadline
n/a
Contract Start
n/a
Contract End
n/a
Category
goods
CPV
33651500 - Immune sera and immunoglobulins
Region
n/a
Awarded To
Bio Products Laboratory Ltd, Grifols UK Ltd.
Official Source
Open Find a Tender

Description

Contracts for the supply of immunoglobulin products

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot Title: Lot 1 - Rabies immunoglobulin solution for injection

Lot Description: Contract for the provision of Rabies immunoglobulin solution for injection. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Lot 1 Status: cancelled

Lot 1 Has Options: Yes

Lot 1 Options: This contract has the option to be extended for a period or periods up to an additional 24 months

Lot 1 Award Criterion (quality): Comparison with specification

Lot 1 Award Criterion (quality): Risk to programme delivery

Lot 1 Award Criterion (quality): Social value

Lot 1 Award Criterion (cost): Benchmark price

Lot 1 Award Criterion (cost): Price

Lot 1 Award Criterion (cost): Additional costs

Lot 1 Award Criterion (cost): Additional savings

Lot 1 Award Criterion (cost): Storage costs

Lot Title: Lot 2 - Human normal immunoglobulin

Lot Description: Contract for the provision of Human normal immunoglobulin. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Lot 2 Status: cancelled

Lot 2 Has Options: Yes

Lot 2 Options: This contract has the option to be extended for a period or periods up to an additional 24 months

Lot 2 Award Criterion (quality): Comparison with specification

Lot 2 Award Criterion (quality): Risk to programme delivery

Lot 2 Award Criterion (quality): Social value

Lot 2 Award Criterion (cost): Benchmark price

Lot 2 Award Criterion (cost): Price

Lot 2 Award Criterion (cost): Additional costs

Lot 2 Award Criterion (cost): Additional savings

Lot 2 Award Criterion (cost): Storage costs

Lot Title: Lot 3 - Hepatitis B immunoglobulin 500IU

Lot Description: Contract for the provision of Hepatitis B immunoglobulin. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Lot 3 Status: cancelled

Lot 3 Has Options: Yes

Lot 3 Options: This contract has the option to be extended for a period or periods up to an additional 24 months

Lot 3 Award Criterion (quality): Comparison with specification

Lot 3 Award Criterion (quality): Risk to programme delivery

Lot 3 Award Criterion (quality): Social value

Lot 3 Award Criterion (cost): Benchmark price

Lot 3 Award Criterion (cost): Price

Lot 3 Award Criterion (cost): Additional costs

Lot 3 Award Criterion (cost): Additional savings

Lot 3 Award Criterion (cost): Storage costs

Lot Title: Lot 4 - Varicella zoster immunoglobulin solution for injection

Lot Description: Contract for the provision of Varicella zoster immunoglobulin solution for injection. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

Lot 4 Status: cancelled

Lot 4 Has Options: Yes

Lot 4 Options: This contract has the option to be extended for a period or periods up to an additional 24 months

Lot 4 Award Criterion (quality): Comparison with specification

Lot 4 Award Criterion (quality): Risk to programme delivery

Lot 4 Award Criterion (quality): Social value

Lot 4 Award Criterion (cost): Benchmark price

Lot 4 Award Criterion (cost): Price

Lot 4 Award Criterion (cost): Additional costs

Lot 4 Award Criterion (cost): Additional savings

Lot 4 Award Criterion (cost): Storage costs

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "id": "009988-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141067",
          "name": "Bio Products Laboratory Ltd"
        }
      ]
    },
    {
      "id": "009988-2025-2",
      "relatedLots": [
        "2"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141068",
          "name": "Grifols UK Ltd."
        }
      ]
    },
    {
      "id": "009988-2025-3",
      "relatedLots": [
        "3"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141067",
          "name": "Bio Products Laboratory Ltd"
        }
      ]
    },
    {
      "id": "009988-2025-4",
      "relatedLots": [
        "4"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-141068",
          "name": "Grifols UK Ltd."
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "21",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      },
      {
        "id": "26",
        "measure": "bids",
        "relatedLot": "2",
        "value": 1
      },
      {
        "id": "31",
        "measure": "bids",
        "relatedLot": "3",
        "value": 1
      },
      {
        "id": "36",
        "measure": "bids",
        "relatedLot": "4",
        "value": 1
      },
      {
        "id": "22",
        "measure": "smeBids",
        "relatedLot": "1",
        "value": 0
      },
      {
        "id": "27",
        "measure": "smeBids",
        "relatedLot": "2",
        "value": 0
      },
      {
        "id": "32",
        "measure": "smeBids",
        "relatedLot": "3",
        "value": 0
      },
      {
        "id": "37",
        "measure": "smeBids",
        "relatedLot": "4",
        "value": 0
      },
      {
        "id": "23",
        "measure": "foreignBidsFromEU",
        "relatedLot": "1",
        "value": 0
      },
      {
        "id": "28",
        "measure": "foreignBidsFromEU",
        "relatedLot": "2",
        "value": 0
      },
      {
        "id": "33",
        "measure": "foreignBidsFromEU",
        "relatedLot": "3",
        "value": 0
      },
      {
        "id": "38",
        "measure": "foreignBidsFromEU",
        "relatedLot": "4",
        "value": 0
      },
      {
        "id": "24",
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "1",
        "value": 0
      },
      {
        "id": "29",
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "2",
        "value": 0
      },
      {
        "id": "34",
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "3",
        "value": 0
      },
      {
        "id": "39",
        "measure": "foreignBidsFromNonEU",
        "relatedLot": "4",
        "value": 0
      },
      {
        "id": "25",
        "measure": "electronicBids",
        "relatedLot": "1",
        "value": 1
      },
      {
        "id": "30",
        "measure": "electronicBids",
        "relatedLot": "2",
        "value": 1
      },
      {
        "id": "35",
        "measure": "electronicBids",
        "relatedLot": "3",
        "value": 1
      },
      {
        "id": "40",
        "measure": "electronicBids",
        "relatedLot": "4",
        "value": 1
      }
    ]
  },
  "buyer": {
    "id": "GB-FTS-91907",
    "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
  },
  "contracts": [
    {
      "awardID": "009988-2025-1",
      "dateSigned": "2025-02-19T00:00:00Z",
      "id": "009988-2025-1",
      "status": "active",
      "value": {
        "amount": 1.0,
        "currency": "GBP"
      }
    },
    {
      "awardID": "009988-2025-2",
      "dateSigned": "2025-02-26T00:00:00Z",
      "id": "009988-2025-2",
      "status": "active",
      "value": {
        "amount": 1.0,
        "currency": "GBP"
      }
    },
    {
      "awardID": "009988-2025-3",
      "dateSigned": "2025-02-19T00:00:00Z",
      "id": "009988-2025-3",
      "status": "active",
      "value": {
        "amount": 1.0,
        "currency": "GBP"
      }
    },
    {
      "awardID": "009988-2025-4",
      "dateSigned": "2025-02-26T00:00:00Z",
      "id": "009988-2025-4",
      "status": "active",
      "value": {
        "amount": 1.0,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-03-18T16:10:58Z",
  "description": "The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.\u003cbr/\u003e\u003cbr/\u003eValue - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.",
  "id": "009988-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-047b9e",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "E14 4PU",
        "region": "UKI42",
        "streetAddress": "10 South Colonnade"
      },
      "contactPoint": {
        "email": "vmc.vaccines@ukhsa.gov.uk",
        "name": "Chantal Jockel"
      },
      "details": {
        "buyerProfile": "https://www.gov.uk/government/organisations/uk-health-security-agency",
        "classifications": [
          {
            "description": "Ministry or any other national or federal authority, including their regional or local subdivisions",
            "id": "MINISTRY",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://www.gov.uk/government/organisations/uk-health-security-agency"
      },
      "id": "GB-FTS-91907",
      "identifier": {
        "legalName": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
      },
      "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Elstree",
        "region": "UK"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-FTS-141067",
      "identifier": {
        "legalName": "Bio Products Laboratory Ltd"
      },
      "name": "Bio Products Laboratory Ltd",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Cambridge",
        "postalCode": "CB25 9PE",
        "region": "UK"
      },
      "details": {
        "scale": "large"
      },
      "id": "GB-FTS-141068",
      "identifier": {
        "legalName": "Grifols UK Ltd."
      },
      "name": "Grifols UK Ltd.",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "WC2A 2LL",
        "streetAddress": "The Strand"
      },
      "details": {
        "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
      },
      "id": "GB-FTS-1661",
      "identifier": {
        "legalName": "The High Court"
      },
      "name": "The High Court",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Immune sera and immunoglobulins",
      "id": "33651500",
      "scheme": "CPV"
    },
    "coveredBy": [
      "GPA"
    ],
    "description": "Contracts for the supply of immunoglobulin products",
    "id": "CM/PHV/25/C262279",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Immune sera and immunoglobulins",
            "id": "33651500",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "deliveryLocation": {
          "description": "UK"
        },
        "id": "1",
        "relatedLot": "1"
      },
      {
        "additionalClassifications": [
          {
            "description": "Immune sera and immunoglobulins",
            "id": "33651500",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "deliveryLocation": {
          "description": "UK"
        },
        "id": "2",
        "relatedLot": "2"
      },
      {
        "additionalClassifications": [
          {
            "description": "Immune sera and immunoglobulins",
            "id": "33651500",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "deliveryLocation": {
          "description": "UK"
        },
        "id": "3",
        "relatedLot": "3"
      },
      {
        "additionalClassifications": [
          {
            "description": "Immune sera and immunoglobulins",
            "id": "33651500",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "deliveryLocation": {
          "description": "UK"
        },
        "id": "4",
        "relatedLot": "4"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "N/A",
              "name": "Comparison with specification",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Risk to programme delivery",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Social value",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Benchmark price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional costs",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional savings",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Storage costs",
              "type": "cost"
            }
          ]
        },
        "description": "Contract for the provision of Rabies immunoglobulin solution for injection. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.",
        "hasOptions": true,
        "id": "1",
        "options": {
          "description": "This contract has the option to be extended for a period or periods up to an additional 24 months"
        },
        "status": "cancelled",
        "title": "Lot 1 - Rabies immunoglobulin solution for injection"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "N/A",
              "name": "Comparison with specification",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Risk to programme delivery",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Social value",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Benchmark price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional costs",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional savings",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Storage costs",
              "type": "cost"
            }
          ]
        },
        "description": "Contract for the provision of Human normal immunoglobulin. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.",
        "hasOptions": true,
        "id": "2",
        "options": {
          "description": "This contract has the option to be extended for a period or periods up to an additional 24 months"
        },
        "status": "cancelled",
        "title": "Lot 2 - Human normal immunoglobulin"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "N/A",
              "name": "Comparison with specification",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Risk to programme delivery",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Social value",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Benchmark price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional costs",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional savings",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Storage costs",
              "type": "cost"
            }
          ]
        },
        "description": "Contract for the provision of Hepatitis B immunoglobulin. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.",
        "hasOptions": true,
        "id": "3",
        "options": {
          "description": "This contract has the option to be extended for a period or periods up to an additional 24 months"
        },
        "status": "cancelled",
        "title": "Lot 3 - Hepatitis B immunoglobulin 500IU"
      },
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "N/A",
              "name": "Comparison with specification",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Risk to programme delivery",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Social value",
              "type": "quality"
            },
            {
              "description": "N/A",
              "name": "Benchmark price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Price",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional costs",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Additional savings",
              "type": "cost"
            },
            {
              "description": "N/A",
              "name": "Storage costs",
              "type": "cost"
            }
          ]
        },
        "description": "Contract for the provision of Varicella zoster immunoglobulin solution for injection. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.",
        "hasOptions": true,
        "id": "4",
        "options": {
          "description": "This contract has the option to be extended for a period or periods up to an additional 24 months"
        },
        "status": "cancelled",
        "title": "Lot 4 - Varicella zoster immunoglobulin solution for injection"
      }
    ],
    "mainProcurementCategory": "goods",
    "procurementMethod": "open",
    "procurementMethodDetails": "Open procedure",
    "status": "complete",
    "title": "Immunoglobulins (2025)"
  }
}